Unity Biotechnology Inc (NAS:UBX)
$ 0.999 -0.036 (-3.48%) Market Cap: 16.83 Mil Enterprise Value: 9.10 Mil PE Ratio: 0 PB Ratio: 1.19 GF Score: 32/100

UNITY Biotechnology Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 12:40PM GMT
Release Date Price: $75.9 (+5.56%)
Unidentified Analyst

I'm [Albert Wong] with Morgan Stanley. I have with me, Keith Leonard, who is the Chairman and CEO of Unity. Keith has been there in that role since 2016 and was previously the CEO of KYTHERA. Prior to KYTHERA , Keith was at Amgen and ran the European operations as well as other functions at Amgen. Welcome, Keith.

Keith R. Leonard
Unity Biotechnology, Inc. - Executive Chairman & CEO

Thank you.

Unidentified Analyst

Maybe just very quickly if you can give a brief introduction to Unity and let the audience know a little bit about what the company is and what healthspan is.

Keith R. Leonard
Unity Biotechnology, Inc. - Executive Chairman & CEO

Sure. So we're a company focused on healthspan, and I'll give you a little background on that. Healthspan is the time we define as when you're functionally young, free of many of the diseases of aging that affect the quality of your life as you age, things like osteoarthritis or loss of vision. And in the last 20-or-so

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot